Apply to Win a Chance to Accelerate Your Company with Takeda Canada!
Innovation across the healthcare ecosystem is key to unlocking the full potential of digital and data for improved patient outcomes. To make a bigger impact on people’s lives, Takeda Canada is opening its doors to new partnerships that will accelerate the future of personalized healthcare. Takeda is launching this call for applications to foster collaborations in digital health and redefine the patient journey.
Requirements:Takeda Canada is looking for innovative solutions in the following therapeutic areas:
- Inflammatory Bowel Disease (Ulcerative Colitis or Crohn's Disease)
- Rare Genetic Diseases (Lysosomal Storage Disorders, Hereditary Angioedema)
Applications are open to innovative organizations based in Canada with solutions in:
- Integrated & Personalized Care
- Early Diagnosis
Benefits:The winner(s) will receive:
- A dedicated point of contact at Takeda Canada
- Direct feedback about potential collaboration after the Takeda Canada Innovation Challenge
- Access to Takeda’s resources and expertise
- A dedicated budget to fund a proof-of-concept project (subject to maximum funding, completion of Takeda’s third-party risk management due diligence, and a funding agreement with Takeda Canada)
- Opportunities to leverage Takeda’s internal expertise and international network of partners and suppliers
Application Deadline: February 6th, 2022
For more information, visit the Takeda Canada Innovation Challenge 2022 website.
